Camp4 Therapeutics Corp

Camp4 Therapeutics Corp (CAMP) priced its initial public offering on Oct 11, 2024 at $11.00 per share, below its $14.00–$16.00 range, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $214.6M. Deutsche Bank was lead-left underwriter. Paul Hastings advised the underwriters.

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company developing regulatory RNA-based therapeutics intended to upregulate gene expression and restore healthy protein levels in genetic diseases, using its proprietary RNA Actuating Platform.

Status

IPO

Ticker

CAMP

Exchange

Nasdaq Global Market

Priced

Oct 11, 2024

IPO price

$11.00

Price range

$14.00–$16.00

Market cap at IPO price

$214.6M

First filed

Sep 20, 2024

Underwriters

Deutsche Bank

Underwriters' counsel

Paul Hastings

Sector

Biotech & pharma

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.